Skip to content

Esoxx Protection

by Sofar Swiss SA Switzerland EUDAMED

Ref ESPR-L04CModel Oral solution, sachets of 10ml

EMDN G99

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-07640158970614 Basic UDI-DIDate11 Feb 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Esoxx Protection
Model / Reference
Oral solution, sachets of 10ml, ESPR-L04C
Primary DI / UDI-DI
07640158970614
Basic UDI-DI
B-07640158970614
EMDN Code
G99 Gastrointestinal devices - other
Device Class
Class III
Market of Registration
Italy

Manufacturer details

EUDAMED SRN
CH-MF-000047475
Authorised representative
ALFASIGMA S.P.A. IT-AR-000047395

Other devices from Sofar Swiss SA

See all devices from Sofar Swiss SA →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
Other properties (10)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 373d659d-6522-4bfb-ab61-45c444591df2 61 fields · synced 24 Oct 2026